Mature human milk can be stored safely in a freezer and heated in a microwave oven without loss of fat or carotenoids. The clinically important loss of fat during tube feeding is probably the most important contributing factor to the decrease in lutein and beta-carotene in tube feeding, with only a small role for peroxidation during light-exposure.
Plasma beta-carotene and vitamin A concentrations are lower in BPD infants which may result in a reduction of their antioxidant protection.
The state of the art is that 1 of 20 laboratories does not meet the IFCC criterion, but there are substantial differences between country and between manufacturer groups. Efforts to further improve quality should focus on reducing between-laboratory variation. With some limitations, fresh whole blood and well-defined lyophilized specimens are suitable for purpose.
Background: Removal of cerebral spinal fluid (CSF) is the common treatment of post hemorrhagic ventricular dilatation (PHVD) in newborn infants. Puncture from a subcutaneous ventricular catheter reservoir (SVCR) allows easy CSF removal with minimal discomfort for the patient. Aims: To assess changes in cerebral oxygenation and hemodynamics after serial CSF removal from a SVCR in infants with PHVD. Methods: 6 infants (GA 216-258 days, BW 1490-2901 gram) were included for this study. These patients were studied during CSF drainage at day 1, 3 and 7 after SVCR placement. The amount of CSF removal was 5.5-9.6 ml/kg. Changes in concentration of oxyhemoglobin (Ä cO2Hb) and deoxyhemoglobin (Ä cHHb) were continuously measured using near infrared spectrophotometry. The difference in Ä cO2Hb and Ä cHHb, indicated as Ä cHbD, represents changes in cerebral blood oxygenation. Concentration changes in total hemoglobin (Ä ctHb), calculated as the sum of Ä cO2Hb and Ä cHHb, reflects changes in cerebral blood volume. Changes in cHbD and ctHb were calculated between tϭ0 (start of CSF removal) and at 15, 30 and 60 minutes after CSF removal. Changes in mean cerebral blood flow velocity (Ä CBFV) in the internal carotid artery were intermittently measured using Doppler ultrasound. Physiologic variables (heart rate, arterial oxygen saturation, respiration rate and arterial blood pressure) were recorded. Results: Values are median (interquartile range). * significant changes (p Ͻ0.05, Wilcoxon-signed ranks test). There were no significant changes in physiological parameters. Conclusion: CSF removal from a SVCR results in improvement of cerebral perfusion, particularly the first day after SVCR placement. Cerebral blood oxygenation is only significantly increased at the day of SVCR placement. These changes are probably related to a reduction in intracranial pressure.
Background:Removal of cerebral spinal fluid (CSF) is the common treatment of post hemorrhagic ventricular dilatation (PHVD) in newborn infants. Puncture from a subcutaneous ventricular catheter reservoir (SVCR) allows easy CSF removal with minimal discomfort for the patient.Aims: To assess changes in cerebral oxygenation and hemodynamics after serial CSF removal from a SVCR in infants with PHVD. Methods: 6 infants (GA 216 -258 days, BW 1490 -2901 gram) were included for this study. These patients were studied during CSF drainage at day 1, 3 and 7 after SVCR placement. The amount of CSF removal was 5.5-9.6 ml/kg. Changes in concentration of oxyhemoglobin (Ä cO2Hb) and deoxyhemoglobin (Ä cHHb) were continuously measured using near infrared spectrophotometry. The difference in Ä cO2Hb and Ä cHHb, indicated as Ä cHbD, represents changes in cerebral blood oxygenation. Concentration changes in total hemoglobin (Ä ctHb), calculated as the sum of Ä cO2Hb and Ä cHHb, reflects changes in cerebral blood volume. Changes in cHbD and ctHb were calculated between tϭ0 (start of CSF removal) and at 15, 30 and 60 minutes after CSF removal. Changes in mean cerebral blood flow velocity (Ä CBFV) in the internal carotid artery were intermittently measured using Doppler ultrasound. Physiologic variables (heart rate, arterial oxygen saturation, respiration rate and arterial blood pressure) were recorded. Results:Values are median (interquartile range). * significant changes (p Ͻ0.05, Wilcoxon-signed ranks test). There were no significant changes in physiological parameters.Conclusion: CSF removal from a SVCR results in improvement of cerebral perfusion, particularly the first day after SVCR placement. Cerebral blood oxygenation is only significantly increased at the day of SVCR placement. These changes are probably related to a reduction in intracranial pressure. Antioxidants (e.g. vitamin E and A) play a role in protecting preterm infants from reactive oxygen species) related diseases e.g. bronchopulmonary dysplasia (BPD). Despite adequate supplementation of these antioxidants BPD still remains a major problem in preterm infants and other antioxidants i.e. carotenoids may play a role. In adults the carotenoids lycopene and â-carotene have a protective effect in cancer and cardiovascular diseases. Carotenoids are present in human milk, but not in parenteral nutrients and only some â-carotene in preterm formula. In this study we evaluated whether carotenoid levels are related to oxidative stress or the occurrence of BPD. Methods: The levels of â-and á-carotene, lycopene, vitamin E and A and plasma F2 isosprostane were studied at days 1, 3 en 7 in a group of 60 preterm infants ( . Postnatally lycopene and á-carotene levels decreased (MANOVA both pϽ 0.01), vitamin A remained stable, vitamin E and â-carotene levels rose (MANOVA both pϽ0.01). No differences were found in carotenoid or vitamin levels comparing the healthy, IRDS and BPD groups. Isoprostane levels remained stable during the study period, and did not differ between the groups. ...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.